CDKN1B and cancer: Consistent with this interpretation, we have previously reported that Rb1G/G; Cdkn1b-/- mice (ie. RB and p27 double mutant) have a synthetic cancer phenotype in which the combined mutation creates deficiency in DNA damage induced cell cycle exit [18].